《生命科学》 2015, 27(4): 471-476
摘 要:摘 要:动脉粥样硬化是冠心病等心血管疾病的病理学基础。血管内皮细胞、血管平滑肌细胞和单核/ 巨噬细胞是参与动脉粥样硬化发生发展的重要因素。microRNA 是一类内源性、长约22 个核苷酸的非编码RNA,能够参与调控众多生物学过程,与许多疾病密切相关。miR-146a/b 广泛表达于血管内皮细胞、平滑肌细胞和单核/ 巨噬细胞中,并通过作用于不同靶基因发挥其多样化的生物学功能,参与调控动脉粥样硬化。现就miR-146a/b 与动脉粥样硬化发生发展的关系作一综述。
Abstract: Abstract: Atherosclerosis, the major cause of cardiovascular disease, is a chronic inflammatory disease. Endothelial cells, vascular smooth muscle cells, and monocytes/macrophages are involved in the initiation and development of
atherosclerosis. MicroRNAs are a class of endogenous non-coding RNA, containing about 22 nucleotides, which contribute to many biological processes and diseases. MiR-146a/b are widely detected in endothelial cells, vascular smooth muscle cells, and monocytes/macrophages, which participate in diverse biological functions through targeting several different atherosclerosis genes. Here, this review will summarize the relationship between miR-146a/b and atherosclerosis